June 25, 2013

The healthcare industry continues to prepare for ACA implementation and the expected influx of newly eligible patients, said Emdeon's Kevin Mahoney. Many pharmacies are changing their staffing models in preparation for customers with expanded Medicaid benefits — especially as we approach the New Year. This is a good time for me to remind you to be thinking about your eligibility program.

October 3, 2012

DSN recently caught up with Sajid Syed, president of Acro Pharmaceutical Services, to talk about how the company works with what he calls the "four P's" — the patient, physician, pharmaceutical manufacturer and payer — to provide an array of specialty pharmacy services to clients.

August 24, 2011

Behind every prescription that lands at the pharmacy counter is a series of events that influence the prescriber’s decision. Powered by data from SDI Health, Drug Store News goes inside the examination room in this exclusive report, providing an in-depth look at the critical factors that shape pharmaceutical sales trends and shift market share from one drug to another in 10 key market segments.

July 10, 2014

As lifetime earnings for pharmaceuticals decrease, commercialization expenses increase and payers tighten their belts on reimbursement, life science companies will be faced with shrinking margins over the next few years. In order to maintain basic operating margin levels and continue investing in research and development at current levels, life science manufacturers will be forced to reduce costs by more than $35 billion by 2017, according to results from a new survey of 70 life science organizations from the IMS Institute for Healthcare Informatics.

July 1, 2014

Actavis and Forest Labs. on Monday announced that the U.S. Federal Trade Commission has voted to approve Actavis' proposed acquisition of Forest.

June 27, 2014

AmerisourceBergen on Thursday announced that it has completed the acquisition of a minority stake in Profarma Distribuidora de Produtos Farmacêuticos, a leading pharmaceutical wholesaler in Brazil.

June 27, 2014

Just two months after Labeed Diab was named head of health and wellness at Walmart, Mark Phillips was elevated to the role of VP pharmaceutical merchandising. Phillips assumes command of more than 4,175 retail pharmacy operations that generates $16.8 billion in pharmacy revenue, according to DSN's PoweRx 50. In his new role, Phillips will lead the pharmaceutical merchandising team and report to Diab. Phillips, who most recently served as the senior director of merchandising in small formats, is a long-time buyer for Walmart and may be an indication of Walmart's steadfast commitment to growing pharmacy, health and wellness, especially across Walmart's smaller formats.

June 24, 2014

The Federal Trade Commission is stepping up probes of pay-for-delay settlements — pharmaceutical deals that delay the sale of generic drugs — according to a report published Monday by Bloomberg.

June 20, 2014

Mark Phillips was elevated to the role of VP of pharmaceutical merchandising at Walmart after previously serving as the retailer’s senior director of merchandising for small formats.

June 13, 2014

Following the campaign's six-month anniversary, Fight the Fakes last week announced 11 new partners, bringing the total number of member organizations to 25.

June 13, 2014

New approaches to treating cancer are creating big growth opportunities for the pharmaceutical industry, Moody's Investors Service stated in a report released Thursday titled "Cancer Breakthroughs Bring New Options for Patients and Revenue Streams to Big Pharma."

June 10, 2014

McKesson Canada on Monday announced the appointment of its new president, Alain Champagne.

June 9, 2014

Bayer last week named Dieter Weinand president of Bayer HealthCare Pharmaceuticals effective Aug. 1.

June 9, 2014

Bristol-Myers Squibb has appointed Giovanni Caforio, M.D., as COO.

June 9, 2014

The National Association of Chain Drug Stores announced on Monday the creation of “Vision 2025” to provide attendees with a glimpse of “what comes next” in the industry through technology platforms, displays and interactive experiences.

June 3, 2014

Asana BioSciences, a research and development company specializing in the discovery and development of new chemical and biological entities, on Tuesday announced that it has acquired an early stage branded pharmaceutical discovery platform from Endo Pharmaceuticals.

June 3, 2014

HDMA on Tuesday honored pharmaceutical and consumer product manufacturers at its 2014 Business and Leadership Conference in Phoenix, through the presentation of the Association’s annual Distribution Industry Awards for Notable Achievements in Healthcare (the DIANA awards).

June 2, 2014

Greenstone on Tuesday announced the introduction of nadolol tablets to its generic pharmaceutical product line. The drug is available in dosage strengths of 20-mg x 100, 40-mg x 100 and 80-mg x 100.

May 29, 2014

Gov. Alejandro García Padilla on Wednesday announced an agreement by Puerto Rico Industrial Development Co. with Actavis that will allow the pharmaceutical manufacturer to develop a solid dosage manufacturing and packing facility in its Manati site and expand its current hormone production in Fajardo.

May 22, 2014

More than 10 million Hispanics are eligible to gain health insurance coverage under the Affordable Care Act, representing unparalleled opportunity for businesses aiming to succeed in the emerging health economy focused on delivering consumer-centered care, according to "Hispanics: A growing force in the New Health Economy," a new report from PwC's Health Research Institute.

May 21, 2014

Practice Fusion on Wednesday launched its real-time healthcare database, Insight. With Insight, physicians, researchers and analysts can access analysis sourced from a de-identified subset of more than 81 million patient records.

May 16, 2014

Abbott announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded generics pharmaceutical presence the company reported.

May 15, 2014

Greenstone announced the introduction of rifabutin capsules to its product line. The drug is the authorized generic version of Mycobutin.

May 15, 2014

On May 5 to 9, Armada Health Care hosted its 10th Annual Specialty Pharmacy Summit at the Wynn Hotel in Las Vegas, Nevada.